Suppr超能文献

来自一名变异型慢性肉芽肿病患者骨髓的功能正常和缺陷的中性粒细胞的克隆生长。体外G-CSF、GM-CSF和IFN-γ对氧化爆发缺陷的重建缺乏。

Clonal growth of functionally normal and deficient neutrophils from the bone marrow of a patient with variant chronic granulomatous disease. Lack of reconstitution of oxidative burst defect by G-CSF, GM-CSF, and IFN-gamma in vitro.

作者信息

Oez S, Birkmann J, Kalden J R

机构信息

5. Medizinische Klinik, Klinikum der Stadt Nürnberg, Federal Republic of Germany.

出版信息

Ann Hematol. 1993 Jan;66(1):21-5. doi: 10.1007/BF01737685.

Abstract

To evaluate the effect of colony-stimulating factors and interferon gamma on the oxidative burst capacity of neutrophils in chronic granulomatous disease (CGD) we studied the neutrophils of a patient with variant CGD both from peripheral blood and from bone marrow culture on day 7 and 14. The results revealed that preincubation of peripheral neutrophils for 24 h in medium containing recombinant human granulocyte colony-stimulating factor (rhG-CSF), recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF), and recombinant human interferon gamma (rhIFN-gamma) alone or in combination did not improve the maximal oxidative burst activity measured by MTT assay. The colonies of this patient formed in agar assay were either composed of predominantly nitroblue tetrazolium (NBT)-positive cells or completely unable to reduce NBT. Despite variable colony numbers in the presence of different cytokines, the rate of NBT-positive colonies was less than 17% of the total number of colonies. However, more than 72% of the colonies were NBT positive in controls. In liquid culture, bone marrow cells yielded a comparable rate of NBT-positive and -negative populations at day 7. These data indicate that rhG-CSF, rhGM-CSF, and rhIFN-gamma alone or rhG-CSF and rhGM-CSF in combination with rhIFN-gamma are not able to reconstitute the oxidative burst defect in CGD in vitro. Indeed, regarding colony-forming capacity, the bone marrow cells from the patient responded to CSFs as well as those from control donors did. This fact may warrant the administration of hematopoietic growth factors, at least in variant CGD, in order to enhance the absolute number of functionally normal neutrophils.

摘要

为评估集落刺激因子和干扰素γ对慢性肉芽肿病(CGD)中性粒细胞氧化爆发能力的影响,我们研究了一名变异型CGD患者外周血及骨髓培养第7天和第14天的中性粒细胞。结果显示,外周中性粒细胞在含重组人粒细胞集落刺激因子(rhG-CSF)、重组人粒细胞-巨噬细胞集落刺激因子(rhGM-CSF)和重组人干扰素γ(rhIFN-γ)的培养基中单独或联合预孵育24小时,并未改善通过MTT法测定的最大氧化爆发活性。该患者在琼脂试验中形成的集落主要由硝基蓝四氮唑(NBT)阳性细胞组成或完全无法还原NBT。尽管在不同细胞因子存在下集落数量可变,但NBT阳性集落的比例不到集落总数的17%。然而,对照组中超过72%的集落为NBT阳性。在液体培养中,骨髓细胞在第7天产生的NBT阳性和阴性群体比例相当。这些数据表明,单独的rhG-CSF、rhGM-CSF和rhIFN-γ,或rhG-CSF和rhGM-CSF与rhIFN-γ联合,在体外均无法重建CGD中的氧化爆发缺陷。事实上,就集落形成能力而言,患者的骨髓细胞对集落刺激因子的反应与对照供体的骨髓细胞相同。这一事实可能支持至少在变异型CGD中给予造血生长因子,以增加功能正常中性粒细胞的绝对数量。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验